Cited by 2,836DNA Repair MechanismsCancer-related Molecular PathwaysMicrotubule and mitosis dynamics

Cell-cycle checkpoints and cancer

Kastan, Michael B., Bartek, Jiri·2004·Nature

Abstract

All life on earth must cope with constant exposure to DNA-damaging agents such as the Sun's radiation. Highly conserved DNA-repair and cell-cycle checkpoint pathways allow cells to deal with both endogenous and exogenous sources of DNA damage. How much an individual is exposed to these agents and how their cells respond to DNA damage are critical determinants of whether that individual will develop cancer. These cellular responses are also important for determining toxicities and responses to current cancer therapies, most of which target the DNA.

Integrity signals

Registry

Crossref · 10.1038/nature03097

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CHK1 prevents new origin firing by inhibiting CDK2 through CDC25A degradation, thus hindering the subsequent loading of CDC45 on chromatin to form the pre-initiation complex.

    “CHK1 prevents new origin firing by inhibiting CDK2 through CDC25A degradation, thus hindering the subsequent loading of CDC45 on chromatin to form the pre-initiation complex [34].”
  • Mutations in checkpoint genes cause syndromes with increased cancer proneness or other clinical symptoms, especially neurological defects.

    “The importance of the DNA damage checkpoint in the maintenance of genomic stability is underlined by the existence of many syndromes linked to mutations in checkpoint genes, causing increased cancer proneness or other clinical symptoms, especially neurological defects [13,14]”

    From Mind the gap: keeping UV lesions in check (2011) · cites this paper as [13]

  • p53-mutant mice are cancer prone but their predilection for mesenchymal and lymphoid malignancies rather than epithelial cancers does not match the tumor types most commonly possessing p53 mutations in humans.

    “while p53-mutant mice are cancer prone, we noted that their predilection for mesenchymal and lymphoid malignancies, rather than epithelial cancers, did not represent the tumor types most commonly possessing p53 mutations in humans (101,102).”

    From Telomeres and telomerase in cancer (2010) · cites this paper as [101]

  • Components of DNA repair and DDR pathways have become therapeutic targets and are being tested in laboratory and clinical studies.

    “factors involved in DNA repair and DDR pathways have become therapeutic targets and are currently being tested in both laboratory and clinical studies [151, 222]”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kastan, M. B., & Bartek, J.
Affiliations
St. Jude Children's Research Hospital (US)
Venue
Nature
Published
2004-11
Volume
432
Issue
7015
Pages
316-323
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1965239527
Cited by
2,836
References
98
Citations by year
2026: 61 · 2025: 71 · 2024: 70 · 2023: 111 · 2022: 132 · 2021: 151 · 2020: 144 · 2019: 119 · 2018: 114 · 2017: 130 · 2016: 141 · 2015: 138 · 2014: 151 · 2013: 141 · 2012: 164
FWCI
9.07
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
Keywords
cell cycle checkpoints, DNA damage response, DNA repair, cancer, DNA-damaging agents, radiation, cancer therapy toxicity, carcinogenesis
MeSH terms
Animals, Cell Cycle, DNA Damage, Humans, Neoplasms, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review